BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rössle M. TIPS: 25years later. Journal of Hepatology 2013;59:1081-93. [DOI: 10.1016/j.jhep.2013.06.014] [Cited by in Crossref: 184] [Cited by in F6Publishing: 145] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Lv Y, Han G, Fan D. Hepatic Hydrothorax. Ann Hepatol 2018;17:33-46. [PMID: 29311408 DOI: 10.5604/01.3001.0010.7533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
2 Raissi D, Yu Q, Nisiewicz M, Krohmer S. Parallel transjugular intrahepatic portosystemic shunt with Viatorr® stents for primary TIPS insufficiency: Case series and review of literature . World J Hepatol 2019; 11(2): 217-225 [PMID: 30820271 DOI: 10.4254/wjh.v11.i2.217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Li HB, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Dong XQ, Liu FQ. Pathological Features of Mitochondrial Ultrastructure Predict Susceptibility to Post-TIPS Hepatic Encephalopathy. Can J Gastroenterol Hepatol 2018;2018:4671590. [PMID: 30079331 DOI: 10.1155/2018/4671590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sturm L, Praktiknjo M, Bettinger D, Huber JP, Volkwein L, Schmidt A, Kaeser R, Chang J, Jansen C, Meyer C, Thomas D, Thimme R, Trebicka J, Schultheiß M. Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt. Hepatol Commun 2021;5:650-60. [PMID: 33860123 DOI: 10.1002/hep4.1654] [Reference Citation Analysis]
5 Cai W, Lin H, Qi R, Lin X, Zhao Y, Chen W, Huang Z. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year. Cardiovasc Intervent Radiol 2021. [PMID: 34523022 DOI: 10.1007/s00270-021-02961-8] [Reference Citation Analysis]
6 Piecha F, Radunski UK, Ozga AK, Steins D, Drolz A, Horvatits T, Spink C, Ittrich H, Benten D, Lohse AW, Sinning C, Kluwe J. Ascites control by TIPS is more successful in patients with a lower paracentesis frequency and is associated with improved survival. JHEP Rep. 2019;1:90-98. [PMID: 32039356 DOI: 10.1016/j.jhepr.2019.04.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
7 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Rössle M, Bettinger D, Trebicka J, Klinger C, Praktiknjo M, Sturm L, Caca K, Mücke VT, Radecke K, Engelmann C, Zipprich A, Heinzow H, Meyer C, Tappe U, Appenrodt B, Schmidt A, Lange C, Strassburg C, Zeuzem S, Grandt D, Schmidt H, Moessner J, Berg T, Lammert F, Thimme R, Schultheiß M. A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment. Aliment Pharmacol Ther 2020;52:329-39. [PMID: 32506456 DOI: 10.1111/apt.15811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
9 Luo SH, Chu JG, Huang H, Zhao GR, Yao KC. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy. World J Gastroenterol 2019; 25(9): 1088-1099 [PMID: 30862997 DOI: 10.3748/wjg.v25.i9.1088] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
10 Merz WM, Rüland AM, Hippe V, Poetzsch B, Meyer C, Pollok JM, Gembruch U, Trebicka J. Pregnancy in Budd-Chiari Syndrome: Case Report and Proposed Risk Score. Medicine (Baltimore) 2016;95:e3817. [PMID: 27258526 DOI: 10.1097/MD.0000000000003817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
11 He C, Lv Y, Wang Z, Guo W, Tie J, Li K, Niu J, Zuo L, Yu T, Yuan X, Chen H, Wang Q, Liu H, Bai W, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Wang J, Yin Z, Fan D, Han G. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis. Digestive and Liver Disease 2018;50:1315-23. [DOI: 10.1016/j.dld.2018.05.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
12 Chang J, Dumitrache A, Böhling N, Abu-Omar J, Meyer C, Strobel D, Luetkens J, Luu AM, Rockstroh J, Strassburg CP, Trebicka J, Gonzalez-Carmona MA, Marinova M, Praktiknjo M. Alteration of contrast enhanced ultrasound (CEUS) of hepatocellular carcinoma in patients with cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS). Sci Rep 2020;10:20682. [PMID: 33244180 DOI: 10.1038/s41598-020-77801-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rashidi-Alavijeh J, Kahraman A, Gerken G, Theysohn JM, Willuweit K, Hoyer DP, Lange CM, Buechter M. Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation. Sci Rep 2021;11:13834. [PMID: 34226640 DOI: 10.1038/s41598-021-93392-5] [Reference Citation Analysis]
14 Ge J, Lai JC, Boike JR, German M, Jest N, Morelli G, Spengler E, Said A, Lee A, Hristov A, Desai AP, Junna S, Pokhrel B, Couri T, Paul S, Frenette C, Christian-Miller N, Laurito M, Verna EC, Rahim U, Goel A, Das A, Pine S, Gregory D, VanWagner LB, Kolli KP; Advancing Liver Therapeutic Approaches (ALTA) Study Group. Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. Liver Transpl 2021;27:329-40. [PMID: 33217178 DOI: 10.1002/lt.25949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li Y, Wang F, Chen X, Li B, Meng W, Qin C. Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt: A propensity score matched cohort study. Medicine (Baltimore) 2017;96:e7551. [PMID: 28723777 DOI: 10.1097/MD.0000000000007551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Bucsics T, Hoffman S, Grünberger J, Schoder M, Matzek W, Stadlmann A, Mandorfer M, Schwabl P, Ferlitsch A, Peck-Radosavljevic M, Trauner M, Karner J, Karnel F, Reiberger T. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis. Liver Int 2018;38:1036-44. [PMID: 29091351 DOI: 10.1111/liv.13615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, Senzolo M, Caraceni P, Salerno F, Angeli P, Cioni R, Vitale A, Grosso M, De Gasperi A, D'Amico G, Marzano A;  AISF TIPS Special Conference. Consensus conference on TIPS management: Techniques, indications, contraindications. Dig Liver Dis. 2017;49:121-137. [PMID: 27884494 DOI: 10.1016/j.dld.2016.10.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 36] [Article Influence: 10.4] [Reference Citation Analysis]
18 Wannhoff A, Hippchen T, Gotthardt DN. Editorial: cardiac volume overload and pulmonary hypertension in long-term follow-up of TIPSS patients - authors' reply. Aliment Pharmacol Ther. 2016;43:1235. [PMID: 27137724 DOI: 10.1111/apt.13628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Yang S, He C, Fan X, Ding W, Wu X, Li J. Early Prophylactic Anticoagulation via Transjugular Intrahepatic Route for Portal Vein Thrombosis after Splenectomy in Cirrhotic Portal Hypertension. Journal of Vascular and Interventional Radiology 2015;26:1009-17. [DOI: 10.1016/j.jvir.2015.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Wu W, He C, Han G. Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding: Wu et al. Hepatology 2015;61:1761-2. [DOI: 10.1002/hep.27438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mollaiyan A, Bettinger D, Rössle M. The underdilation of nitinol stents at TIPS implantation: Solution or illusion? European Journal of Radiology 2017;89:123-8. [DOI: 10.1016/j.ejrad.2017.01.032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
22 Luca A, Miraglia R, Maruzzelli L, D’amico M, Tuzzolino F. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors. Radiology 2016;280:622-9. [DOI: 10.1148/radiol.2016151625] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
23 Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2019;31:626-632. [PMID: 30550458 DOI: 10.1097/meg.0000000000001342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Vasconcelos-filho JM, Pereira AH, Pitta GBB, Leitão-batista L, Castro AA, Souza-leão AR, Lacerda CM. Measurements between the hepatic veins and portal venous system, in human cirrhotic liver: a cast study. Surg Radiol Anat 2018;40:395-400. [DOI: 10.1007/s00276-017-1909-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Berry K, Lerrigo R, Liou IW, Ioannou GN. Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016;14:118-123. [PMID: 26192147 DOI: 10.1016/j.cgh.2015.06.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
26 Luo SH, Chu JG, Huang H, Yao KC. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2017; 23(26): 4779-4787 [PMID: 28765699 DOI: 10.3748/wjg.v23.i26.4779] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
27 Yu J, Wang X, Jiang M, Ma H, Zhou Z, Yang L, Li X. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study. Eur Radiol 2019;29:699-706. [PMID: 30039223 DOI: 10.1007/s00330-018-5645-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
28 Miraglia R, Maruzzelli L, Cannataci C, Gerasia R, Mamone G, Cortis K, Cimò B, Petridis I, Volpes R, Luca A. Radiation exposure during transjugular intrahepatic portosystemic shunt creation in patients with complete portal vein thrombosis or portal cavernoma. Radiol med 2020;125:609-17. [DOI: 10.1007/s11547-020-01155-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Pieper CC, Jansen C, Meyer C, Nadal J, Lehmann J, Schild HH, Trebicka J, Thomas D. Prospective Evaluation of Passive Expansion of Partially Dilated Transjugular Intrahepatic Portosystemic Shunt Stent Grafts—A Three-Dimensional Sonography Study. Journal of Vascular and Interventional Radiology 2017;28:117-25. [DOI: 10.1016/j.jvir.2016.06.023] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
30 Bissonnette J, Garcia-Pagán JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, Sibert A, Bouchard L, Perreault P, Trebicka J, Trottier-Tellier F, Rautou PE, Valla DC, Plessier A. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology 2016;64:224-31. [PMID: 26990687 DOI: 10.1002/hep.28547] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
31 McCarty TR, Njei B. Self-expanding metal stents for acute refractory esophageal variceal bleeding: A systematic review and meta-analysis. Dig Endosc. 2016;28:539-547. [PMID: 26845490 DOI: 10.1111/den.12626] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 5.4] [Reference Citation Analysis]
32 Young S, Rostambeigi N, Golzarian J, Lim N. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement. American Journal of Roentgenology 2020;215:215-22. [DOI: 10.2214/ajr.19.21726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
33 Garbuzenko DV, Arefyev NO. Hepatic hydrothorax: An update and review of the literature. World J Hepatol 2017; 9(31): 1197-1204 [PMID: 29152039 DOI: 10.4254/wjh.v9.i31.1197] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
34 Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol 2020;35:278-83. [PMID: 31222830 DOI: 10.1111/jgh.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Luo X, Wang X, Zhu Y, Xi X, Zhao Y, Yang J, Li X, Yang L. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm. Cardiovasc Intervent Radiol 2019;42:737-43. [DOI: 10.1007/s00270-019-02162-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Regnault D, d'Alteroche L, Nicolas C, Dujardin F, Ayoub J, Perarnau JM. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol 2018;30:557-62. [PMID: 29324586 DOI: 10.1097/MEG.0000000000001067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
37 Campos S, Gomes D, Sofia C. Transjugular intrahepatic portosystemic shunt in refractory hydrothorax – a contribution to an unexplored indication: . European Journal of Gastroenterology & Hepatology 2016;28:661-6. [DOI: 10.1097/meg.0000000000000623] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
38 Sakr M, Abdelhakam SM, Elsayed SA, Allam EH, Farid AM, Abdelmoaty W, Hassan AM, Shaker M, El-Gharib M, Eldorry A. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study. World J Gastroenterol 2017; 23(4): 629-637 [PMID: 28216969 DOI: 10.3748/wjg.v23.i4.629] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
39 Miraglia R, Maruzzelli L, Di Piazza A, Mamone G, Caruso S, Gentile G, Tuzzolino F, Floridia G, Petridis I, Volpes R, Luca A. Transjugular Intrahepatic Portosystemic Shunt Using the New Gore Viatorr Controlled Expansion Endoprosthesis: Prospective, Single-Center, Preliminary Experience. Cardiovasc Intervent Radiol 2019;42:78-86. [DOI: 10.1007/s00270-018-2040-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 9.3] [Reference Citation Analysis]
40 Zhang LH, Tong H, Wei B, Wu H, Tang CW. Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis. Chin Med J (Engl) 2017;130:1999-2000. [PMID: 28776556 DOI: 10.4103/0366-6999.211887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Tong H, Gan C, Wei B, Wang ZD, Li XD, Qian SJ, Huan H, Zhang LH, Yang Z, Chen YL, Gu YH, Chen LX, Yang YH, Wu H, Tang CW. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis. J Dig Dis 2021;22:31-40. [PMID: 33128287 DOI: 10.1111/1751-2980.12957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Silva-junior G, Turon F, Baiges A, Cerda E, García-criado Á, Blasi A, Torres F, Hernandez-gea V, Bosch J, Garcia-pagan JC. Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension. Gastroenterology 2017;152:1358-65. [DOI: 10.1053/j.gastro.2017.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
43 Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, Xirouchakis E, Guerrini GP, Burroughs AK, Tsochatzis E, Patch D. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci 2019;64:1335-45. [PMID: 30560334 DOI: 10.1007/s10620-018-5412-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
44 Cai J, Guo W, He C, Han G. Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Journal of Hepatology 2015;62:245-7. [DOI: 10.1016/j.jhep.2014.08.053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
45 Allaire M, Walter A, Sutter O, Nahon P, Ganne-carrié N, Amathieu R, Nault J. TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2020;44:249-63. [DOI: 10.1016/j.clinre.2019.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
46 Jansen C, Möller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A, Schierwagen R, Praktiknjo M, Abdullah Z, Lehmann J, Thomas D, Strassburg CP, Latz E, Mueller S, Rössle M, Trebicka J. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology 2018;67:1472-84. [PMID: 29059466 DOI: 10.1002/hep.29612] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 15.3] [Reference Citation Analysis]
47 Lim SJM, Kelly M, Selvarajah L, Murray M, Scanlon T. Transjugular intrahepatic portosystemic shunt (TIPS) procedure: an assessment of the quality and readability of online information. BMC Med Inform Decis Mak 2021;21:149. [PMID: 33952225 DOI: 10.1186/s12911-021-01513-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2018;. [PMID: 29973706 DOI: 10.1038/s41395-018-0185-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
49 Riedel C, Lenz A, Fischer L, Li J, Piecha F, Kluwe J, Adam G, Bannas P. Abdominal Applications of 4D Flow MRI. Rofo 2021;193:388-98. [PMID: 33264806 DOI: 10.1055/a-1271-7405] [Reference Citation Analysis]
50 Habib A, Desai K, Hickey R, Thornburg B, Vouche M, Vogelzang RL, Salem R. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol 2015;26:499-506. [PMID: 25666626 DOI: 10.1016/j.jvir.2014.12.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
51 Sutcliffe J, Briggs J, Little M, Mccarthy E, Wigham A, Bratby M, Tapping C, Anthony S, Patel R, Phillips-hughes J, Boardman P, Uberoi R. Antibiotics in interventional radiology. Clinical Radiology 2015;70:223-34. [DOI: 10.1016/j.crad.2014.09.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
52 He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World J Gastroenterol 2015; 21(8): 2413-2418 [PMID: 25741149 DOI: 10.3748/wjg.v21.i8.2413] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
53 Dhaliwal A, Armstrong MJ, Tripathi D. Patient Selection for Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion in Variceal Bleeding and Refractory Ascites. Curr Hepatology Rep 2017;16:241-9. [DOI: 10.1007/s11901-017-0361-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol. 2014;11:435-446. [PMID: 24686266 DOI: 10.1038/nrgastro.2014.36] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 11.7] [Reference Citation Analysis]
55 Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. Journal of Hepatology 2017;67:508-16. [DOI: 10.1016/j.jhep.2017.05.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 15.5] [Reference Citation Analysis]
56 Nardelli S, Gioia S, Ridola L, Riggio O. Radiological Intervention for Shunt Related Encephalopathy. J Clin Exp Hepatol 2018;8:452-9. [PMID: 30564003 DOI: 10.1016/j.jceh.2018.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
57 Oey RC, de Wit K, Moelker A, Atalik T, van Delden OM, Maleux G, Erler NS, Takkenberg RB, de Man RA, Nevens F, van Buuren HR. Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study. Aliment Pharmacol Ther 2018;48:975-83. [PMID: 30136292 DOI: 10.1111/apt.14947] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
58 Trebicka J, Bastgen D, Byrtus J, Praktiknjo M, Terstiegen S, Meyer C, Thomas D, Fimmers R, Treitl M, Euringer W, Sauerbruch T, Rössle M. Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival. Clin Gastroenterol Hepatol 2019;17:2793-2799.e1. [PMID: 30940552 DOI: 10.1016/j.cgh.2019.03.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
59 Qi X, Jia J, Bai M, Guo X, Su C, García-Pagán JC, Han G, Fan D. Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis. J Clin Gastroenterol 2015;49:495-505. [PMID: 25127113 DOI: 10.1097/MCG.0000000000000205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
60 Zhang Y, Liu FQ, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL. Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study. World J Clin Cases 2019; 7(12): 1410-1420 [PMID: 31363469 DOI: 10.12998/wjcc.v7.i12.1410] [Reference Citation Analysis]
61 Rössle M, Schupp JC, Köhler TC, Schultheiss M. Editorial: cardiac volume overload and pulmonary hypertension in long-term follow-up of TIPSS patients. Aliment Pharmacol Ther 2016;43:1233-5. [DOI: 10.1111/apt.13599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
62 Miraglia R, Maruzzelli L, Tuzzolino F, Petridis I, D'Amico M, Luca A. Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents. Radiology. 2017;284:281-288. [PMID: 28121521 DOI: 10.1148/radiol.2017161644] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
63 Farsad K, Kolbeck KJ. Clinical and Radiologic Evaluation of Patients Before TIPS Creation. American Journal of Roentgenology 2014;203:739-45. [DOI: 10.2214/ajr.14.12999] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
64 Darrow AW, Gaba RC, Lokken RP. Transhepatic Revision of Occluded Transjugular Intrahepatic Portosystemic Shunt Complicated by Endotipsitis. Semin Intervent Radiol 2018;35:492-6. [PMID: 30728666 DOI: 10.1055/s-0038-1676092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Tan HK, James PD, Sniderman KW, Wong F. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion. J Gastroenterol Hepatol. 2015;30:389-395. [PMID: 25168607 DOI: 10.1111/jgh.12725] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
66 Vidal-González J, Quiroga S, Simón-Talero M, Genescà J. Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem. Therap Adv Gastroenterol 2020;13:1756284820961287. [PMID: 33062057 DOI: 10.1177/1756284820961287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
67 Win AZ. Image guided portal vein access techniques in TIPS creation and considerations regarding their use. Ann Transl Med 2016;4:226. [PMID: 27385392 DOI: 10.21037/atm.2016.05.43] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
68 Zhou Y, Zhang W, Zhang Z, Luo J, Gu J, Liu Q, Ma J, Yan Z, Chen S, Wang J. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020;32:1235-43. [PMID: 32744824 DOI: 10.1097/MEG.0000000000001686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Rössle M, Bausch B, Klinger C. Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View. Viszeralmedizin 2014;30:401-8. [PMID: 26288607 DOI: 10.1159/000370053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
70 Gioia S, Merli M, Nardelli S, Lattanzi B, Pitocchi F, Ridola L, Riggio O. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int. 2019;39:871-877. [PMID: 30667572 DOI: 10.1111/liv.14050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
71 Schultheiß M, Giesler M, Maruschke L, Schmidt A, Sturm L, Thimme R, Rössle M, Bettinger D. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization. Cardiovasc Intervent Radiol 2019;42:729-36. [PMID: 30788517 DOI: 10.1007/s00270-019-02176-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
72 Seifert LL, Görlich D, Jansen C, Ortmann O, Schoster M, Praktiknjo M, Gu W, Schindler P, Köhler M, Maschmeier M, Wilms C, Meyer C, Schmidt HH, Wildgruber M, Trebicka J, Heinzow H. Evaluation of impact of elective invasive examinations in patients with transjugular intrahepatic portosystemic shunt in the long-term follow up. Z Gastroenterol 2021;59:24-34. [PMID: 33429447 DOI: 10.1055/a-1330-9867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Luo X, Zhao M, Wang X, Jiang M, Yu J, Li X, Yang L. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PLoS One 2019;14:e0212658. [PMID: 30811467 DOI: 10.1371/journal.pone.0212658] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
74 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology. 2016;278:333-353. [PMID: 26789601 DOI: 10.1148/radiol.2015141858] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
75 Glowka TR, Kalff JC, Schäfer N. Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon’s Point of View. Viszeralmedizin. 2014;30:409-415. [PMID: 26288608 DOI: 10.1159/000369575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, Almasio PL. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol 2013; 5(12): 685-691 [PMID: 24432185 DOI: 10.4254/wjh.v5.i12.685] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
77 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: An evidence-based review. World J Gastroenterol 2014; 20(21): 6470-6480 [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
78 Nardelli S, Lattanzi B, Torrisi S, Greco F, Farcomeni A, Gioia S, Merli M, Riggio O. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. Clin Gastroenterol Hepatol. 2017;15:934-936. [PMID: 27816756 DOI: 10.1016/j.cgh.2016.10.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 14.6] [Reference Citation Analysis]
79 Zurera LJ, Espejo JJ, Lombardo S, Gilbert JJ, Canis M, Ruiz C. Safety and efficacy of expanded polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts in children with acute or recurring upper gastrointestinal bleeding. Pediatr Radiol 2015;45:422-9. [DOI: 10.1007/s00247-014-3181-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
80 Gaba RC, Parvinian A, Minocha J, Casadaban LC, Knuttinen MG, Ray CE, Bui JT. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated? J Vasc Interv Radiol. 2015;26:382-387. [PMID: 25735521 DOI: 10.1016/j.jvir.2014.08.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
81 Zheng D, Yu J, Li H, Gan H, Wang J, Jiang T, Ren H, Wu F. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertension: Case series. Medicine (Baltimore) 2021;100:e26610. [PMID: 34232216 DOI: 10.1097/MD.0000000000026610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Lenci I, Neri B, Morosetti D, Milana M, Palmieri G, Tisone G, Orlacchio A, Angelico M, Baiocchi L. Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant. Ann Hepatol 2021;22:100162. [PMID: 31862175 DOI: 10.1016/j.aohep.2019.11.005] [Reference Citation Analysis]
83 Tacher V, Petit A, Derbel H, Novelli L, Vitellius M, Ridouani F, Luciani A, Rahmouni A, Duvoux C, Salloum C, Chiaradia M, Kobeiter H. Three-dimensional Image Fusion Guidance for Transjugular Intrahepatic Portosystemic Shunt Placement. Cardiovasc Intervent Radiol 2017;40:1732-9. [DOI: 10.1007/s00270-017-1699-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
84 Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51:190-205. [PMID: 30606696 DOI: 10.1016/j.dld.2018.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
85 Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol. 2015;9:865-875. [PMID: 25754880 DOI: 10.1586/17474124.2015.1024224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
86 Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol 2016; 22(1): 89-102 [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
87 De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA, Forlino M, Farcomeni A, Riggio O. Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2018;33:704-9. [PMID: 28753738 DOI: 10.1111/jgh.13907] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
88 Wannhoff A, Hippchen T, Weiss CS, Friedrich K, Rupp C, Neumann-Haefelin C, Dollinger M, Antoni C, Stampfl U, Schemmer P, Stremmel W, Weiss KH, Radeleff B, Katus HA, Gotthardt DN. Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt. Aliment Pharmacol Ther. 2016;43:955-965. [PMID: 26919285 DOI: 10.1111/apt.13569] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
89 Gunasekaran SS, Gaba RC. Anatomic Variations of the Right Portal Vein: Prevalence, Imaging Features, and Implications for Successful Transjugular Intrahepatic Portosystemic Shunt Creation. J Clin Imaging Sci 2017;7:14. [PMID: 28515965 DOI: 10.4103/jcis.JCIS_10_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
90 Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Creation With Embolization or Obliteration for Variceal Bleeding. Techniques in Vascular and Interventional Radiology 2016;19:21-35. [DOI: 10.1053/j.tvir.2016.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
91 Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol 2015; 7(3): 304-314 [PMID: 25848460 DOI: 10.4254/wjh.v7.i3.304] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
92 Trebicka J. Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close? J Hepatol. 2017;66:442-450. [PMID: 27984174 DOI: 10.1016/j.jhep.2016.10.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 9.6] [Reference Citation Analysis]
93 Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. J Hepatol 2021;74:1362-72. [PMID: 33508376 DOI: 10.1016/j.jhep.2021.01.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
94 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Reference Citation Analysis]
95 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
96 Stirnimann G, Ebadi M, Tandon P, Montano-Loza AJ. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication? Curr Gastroenterol Rep. 2018;20:50. [PMID: 30259203 DOI: 10.1007/s11894-018-0656-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
97 Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol 2014; 20(45): 16996-17010 [PMID: 25493012 DOI: 10.3748/wjg.v20.i45.16996] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
98 Müller M, Seufferlein T, Perkhofer L, Wagner M, Kleger A. Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study. PLoS One 2015;10:e0126525. [PMID: 26098635 DOI: 10.1371/journal.pone.0126525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
99 Maschke SK, Werncke T, Renne J, Kloeckner R, Marquardt S, Kirstein MM, Potthoff A, Wacker FK, Meyer BC, Hinrichs JB. Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction: quantitative assessment of flow and perfusion changes using 2D-perfusion angiography following shunt revision. Abdom Radiol 2018;43:2868-75. [DOI: 10.1007/s00261-018-1547-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Amin AA, Alabsawy EI, Jalan R, Davenport A. Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome. Seminars in Nephrology 2019;39:17-30. [DOI: 10.1016/j.semnephrol.2018.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
101 He F, Zhao H, Dai S, Wu Y, Wang L, Huang H, Yue Z, Fan Z, Dong X, Liu F. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep. 2016;6:36380. [PMID: 27805025 DOI: 10.1038/srep36380] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
102 Poincloux L, Chabrot P, Mulliez A, Genes J, Boyer L, Abergel A. Interventional endoscopic ultrasound: A new promising way for intrahepatic portosystemic shunt with portal pressure gradient. Endosc Ultrasound 2017;6:394-401. [PMID: 29251274 DOI: 10.4103/eus.eus_42_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
103 Lerrigo R, Beste LA, Leipertz SL, Green PK, Lok AS, Kogut MJ, Ioannou GN. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System. Eur J Gastroenterol Hepatol 2016;28:667-75. [PMID: 26886386 DOI: 10.1097/MEG.0000000000000604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
104 Kumar R, Kerbert AJC, Sheikh MF, Roth N, Calvao JAF, Mesquita MD, Barreira AI, Gurm HS, Ramsahye K, Mookerjee RP, Yu D, Davies NH, Mehta G, Agarwal B, Patch D, Jalan R. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. J Hepatol 2021;74:66-79. [PMID: 32561318 DOI: 10.1016/j.jhep.2020.06.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
105 Kawahara Y, Tanaka Y, Isoi N, Hatanaka K, Yamada K, Yamamoto M, Okamura T, Kaji T, Sakamoto T, Saitoh D, Ikeuchi H. Direct intrahepatic portocaval shunt for refractory hepatic hydrothorax: a case report. Acute Med Surg 2017;4:306-10. [PMID: 29123879 DOI: 10.1002/ams2.257] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
106 Storace M, Martin JG, Shah J, Bercu Z. CTA As an Adjuvant Tool for Acute Intra-abdominal or Gastrointestinal Bleeding. Techniques in Vascular and Interventional Radiology 2017;20:248-57. [DOI: 10.1053/j.tvir.2017.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
107 Attia D, Rodt T, Marquardt S, Hinrichs J, Meyer BC, Gebel M, Wacker F, Manns MP, Potthoff A. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient. Abdom Radiol 2019;44:1127-34. [DOI: 10.1007/s00261-018-1795-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
108 Lauermann J, Potthoff A, Mc Cavert M, Marquardt S, Vaske B, Rosenthal H, von Hahn T, Wacker F, Meyer BC, Rodt T. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device. Cardiovasc Intervent Radiol 2016;39:547-56. [DOI: 10.1007/s00270-015-1209-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
109 Qi X, Tian Y, Zhang W, Yang Z, Guo X. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Therap Adv Gastroenterol 2017;10:32-41. [PMID: 28286557 DOI: 10.1177/1756283X16671286] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
110 Sauerbruch T, Trebicka J. Future therapy of portal hypertension in liver cirrhosis - a guess. F1000Prime Rep. 2014;6:95. [PMID: 25374673 DOI: 10.12703/P6-95] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
111 Steib CJ, Li H, Zhang J, Mayerle J, Ricke J, Gerbes AL, Meyer C, Zipprich A, Trebicka J. Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals. European Journal of Gastroenterology & Hepatology 2020;32:1179-85. [DOI: 10.1097/meg.0000000000001628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
112 Liu J, Ma J, Yang C, Ye T, Meng J, Shi Q, Xiong B. Impact of TIPS on Splenic Volume and Thrombocytopenia. AJR Am J Roentgenol 2021;216:698-703. [PMID: 33439047 DOI: 10.2214/AJR.20.22958] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015;99:2347-2355. [PMID: 25905983 DOI: 10.1097/tp.0000000000000729] [Cited by in Crossref: 78] [Cited by in F6Publishing: 16] [Article Influence: 15.6] [Reference Citation Analysis]
114 Chen WC, Hsin IF, Chen PH, Hsu PI, Wang YP, Cheng JS, Lin HS, Hou MC, Lee FY. Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis.Clin Gastroenterol Hepatol. 2019;17:2356-2363. [PMID: 30772583 DOI: 10.1016/j.cgh.2019.02.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
115 Sturm L, Bettinger D, Giesler M, Boettler T, Schmidt A, Buettner N, Thimme R, Schultheiss M. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS). United European Gastroenterol J 2018;6:1380-90. [PMID: 30386611 DOI: 10.1177/2050640618795928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
116 Bucher JN, Hollenbach M, Strocka S, Gaebelein G, Moche M, Kaiser T, Bartels M, Hoffmeister A. Segmental intrahepatic cholestasis as a technical complication of the transjugular intrahepatic porto-systemic shunt. World J Gastroenterol 2019; 25(43): 6430-6439 [PMID: 31798279 DOI: 10.3748/wjg.v25.i43.6430] [Reference Citation Analysis]
117 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
118 Bettinger D, Schultheiss M, Boettler T, Muljono M, Thimme R, Rössle M. Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Aliment Pharmacol Ther 2016;44:1051-61. [DOI: 10.1111/apt.13809] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
119 Tandon B, Ramachandran J, Narayana S, Muller K, Pathi R, Wigg AJ. Outcomes of transjugular intrahepatic portosystemic shunt procedures: a 10-year experience. J Med Imaging Radiat Oncol 2021. [PMID: 33687155 DOI: 10.1111/1754-9485.13168] [Reference Citation Analysis]
120 Stankovic Z, Rössle M, Euringer W, Schultheiss M, Salem R, Barker A, Carr J, Langer M, Markl M, Collins JD. Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI. Eur Radiol. 2015;25:2634-2640. [PMID: 25850890 DOI: 10.1007/s00330-015-3663-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
121 Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, Zhang L, Wang Q, Liu H, Luo B. Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis. Radiology. 2017;285:999-1010. [PMID: 28682164 DOI: 10.1148/radiol.2017162266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
122 Lipnik AJ, Pandhi MB, Khabbaz RC, Gaba RC. Endovascular Treatment for Variceal Hemorrhage: TIPS, BRTO, and Combined Approaches. Semin Intervent Radiol 2018;35:169-84. [PMID: 30087520 DOI: 10.1055/s-0038-1660795] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
123 Liu J, Ma J, Zhou C, Yang C, Huang S, Shi Q, Xiong B. Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation. Clin Transl Gastroenterol 2021;12:e00376. [PMID: 34140457 DOI: 10.14309/ctg.0000000000000376] [Reference Citation Analysis]
124 Fanelli F. The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips. ISRN Hepatol 2014;2014:762096. [PMID: 27335841 DOI: 10.1155/2014/762096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
125 Song T, Rössle M, He F, Liu F, Guo X, Qi X. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis. Dig Liver Dis 2018;50:323-30. [PMID: 29422242 DOI: 10.1016/j.dld.2018.01.123] [Cited by in F6Publishing: 24] [Reference Citation Analysis]
126 Zhou Y, Ma J, Ju S, Zhang Z, Zhang W, Yang M, Zhou X, Yan Z, Luo J. Efficacy of puncturing different portal vein branch during transjugular intrahepatic portosystemic shunt with 8 mm covered stent: a propensity-score analysis. Eur J Gastroenterol Hepatol 2021;33:1110-6. [PMID: 33741800 DOI: 10.1097/MEG.0000000000002133] [Reference Citation Analysis]
127 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
128 Zhao R, Lu J, Shi Y, Zhao H, Xu K, Sheng J. Current management of refractory ascites in patients with cirrhosis. J Int Med Res 2018;46:1138-45. [PMID: 29210304 DOI: 10.1177/0300060517735231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
129 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
130 Zhang H, Zhang H, Li H, Zhang H, Zheng D, Sun CM, Wu J. TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update. J Huazhong Univ Sci Technolog Med Sci 2017;37:475-85. [PMID: 28786052 DOI: 10.1007/s11596-017-1760-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
131 Shao XD, Qi XS, Guo XZ. Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. Biomed Res Int. 2016;2016:4054513. [PMID: 27517043 DOI: 10.1155/2016/4054513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
132 Pieper CC, Sprinkart AM, Nadal J, Hippe V, Meyer C, Schild HH, Thomas D. Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents. J Vasc Interv Radiol. 2015;26:388-394. [PMID: 25541420 DOI: 10.1016/j.jvir.2014.10.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
133 Nicolas C, d’Alteroche L, Perarnau J. Reply to: “Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?”. Journal of Hepatology 2015;62:247-8. [DOI: 10.1016/j.jhep.2014.09.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
134 Luo X, Ye L, Zhou X, Tsauo J, Zhou B, Zhang H, Zhang X, Li X. C-Arm Cone-Beam Volume CT in Transjugular Intrahepatic Portosystemic Shunt: Initial Clinical Experience. Cardiovasc Intervent Radiol. 2015;38:1627-1631. [PMID: 25832762 DOI: 10.1007/s00270-015-1087-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
135 Trivedi PS, Rochon PJ, Durham JD, Ryu RK. National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample. Journal of Vascular and Interventional Radiology 2016;27:838-45. [DOI: 10.1016/j.jvir.2015.12.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
136 Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G;  PVT-TIPS Study Group. Covered TIPS vs endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67:2156-2168. [PMID: 28970291 DOI: 10.1136/gutjnl-2017-314634] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 15.3] [Reference Citation Analysis]
137 Praktiknjo M, Abu-Omar J, Chang J, Thomas D, Jansen C, Kupczyk P, Schepis F, Garcia-Pagan JC, Merli M, Meyer C, Strassburg CP, Pieper CC, Trebicka J. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 2021;3:100264. [PMID: 34013182 DOI: 10.1016/j.jhepr.2021.100264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
138 Nardelli S, Ridola L, Gioia S, Riggio O. Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments. Curr Treat Options Gastro 2018;16:253-9. [DOI: 10.1007/s11938-018-0183-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
139 Wang Z, Jiang MS, Zhang HL, Weng NN, Luo XF, Li X, Yang L. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? Radiology. 2016;279:943-951. [PMID: 26653681 DOI: 10.1148/radiol.2015150369] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 8.7] [Reference Citation Analysis]
140 David A, Liberge R, Meyer J, Morla O, Leaute F, Archambeaud I, Gournay J, Trewick D, Frampas E, Perret C, Douane F. Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement. Diagnostic and Interventional Imaging 2019;100:445-53. [DOI: 10.1016/j.diii.2019.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
141 Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, Caca K. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Digestive and Liver Disease 2017;49:1345-52. [DOI: 10.1016/j.dld.2017.05.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
142 Santos S, Dantas E, Veloso Gomes F, Luz JH, Vasco Costa N, Bilhim T, Calinas F, Martins A, Coimbra É. Retrospective Study of Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhotic Portal Hypertension. GE Port J Gastroenterol 2020;28:5-12. [PMID: 33564700 DOI: 10.1159/000507894] [Reference Citation Analysis]
143 Wolter K, Praktiknjo M, Boie J, Decker G, Nadal J, Jansen C, Keller WIY, Meyer C, Trebicka J, Attenberger U, Thomas D. Glue Embolization of Gastroesophageal Varices during Transjugular Intrahepatic Portosystemic Shunt (TIPS) Improves Survival Compared to Coil-only Embolization-A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2021;44:1240-50. [PMID: 34021379 DOI: 10.1007/s00270-021-02852-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Fukui H, Kawaratani H, Kaji K, Takaya H, Yoshiji H. Management of refractory cirrhotic ascites: challenges and solutions. Hepat Med. 2018;10:55-71. [PMID: 30013405 DOI: 10.2147/hmer.s136578] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
145 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 15.5] [Reference Citation Analysis]